Access cutting-edge liver transplant treatment through this clinical trial at a research site in San Francisco. Study-provided care at no cost to qualified participants.
Access liver transplant specialists in San Francisco at no cost
This study follows strict safety protocols and ethical guidelines
All study-related liver transplant treatment provided free
This is a multi-center clinical trial in Cytomegalovirus (CMV) seronegative prospective liver transplant recipients to determine the efficacy of two doses of Cytomegalovirus-Modified Vaccinia Ankara (CMV-MVA) Triplex CMV vaccine pre-transplant. The primary objective is to assess the effect of pre-transplant (Tx) Triplex vaccination on duration of CMV antiviral therapy (AVT) within the first 100 days post-Tx in CMV seropositive donor (D+) and seronegative (R-) (D+R-) liver transplant recipients (
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Check if you qualify for this liver transplant clinical trial in San Francisco, CA
If you're searching for liver transplant treatment options in San Francisco, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our San Francisco research site is actively enrolling participants for this clinical trial. You'll receive care from experienced liver transplant specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.